Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
International Journal of Clinical Practice|January 6, 2000
Management of hypertension and its sequelae with ACE inhibitors: biochemical, pharmacological and clinical aspectsB Rangoonwala, I RosenthalInternational Journal of Clinical Practice|December 23, 2003
Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal diseaseF Cantarovich, B RangoonwalaThe British Journal of Clinical Practice|December 1, 1996
Fixed dose combinations of ACE inhibitorsB Rangoonwala, W Schulz, B BauerPharmatherapeutica|January 1, 1986
Efficacy of a low fixed-dose combination of penbutolol with piretanide in the treatment of mild to moderate hypertension: a double-blind study against placeboJ Yasky, M Verho, B RangoonwalaCurrent Medical Research and Opinion|January 1, 1987
Efficacy of a fixed-dose combination of 40 mg penbutolol with 6 mg piretanide in the treatment of mild to moderate hypertension: a double-blind study against placeboJ Yasky, M Verho, B RangoonwalaMMW Fortschritte Der Medizin|July 24, 2002
[ACE inhibitor or AT1 antagonist. Is there a differential therapy?]Th Unger, B Rangoonwala, J RosenthalEuropean Journal of Clinical Pharmacology|January 1, 1985
Single and divided daily dose piretanide in the treatment of uncomplicated essential hypertension: a double-blind comparison with a combination of hydrochlorothiazide and amilorideM Verho, B Rangoonwala, W DolsWiener Medizinische Wochenschrift (1946)|April 30, 1985
[Comparative study of 2 diuretic-containing combination preparations in patients with edematous heart failure]H Mauersberger, B Rangoonwala, E EhrlichPharmatherapeutica|January 1, 1982
Efficacy of penbutolol and a fixed combination of penbutolol with furosemide in the treatment of hypertensionE Haeringer, W Graml, B Rangoonwala, et al.The Journal of International Medical Research|January 1, 1985
Piretanide, a potassium stable diuretic, in the treatment of essential hypertension: a double-blind comparison of two formulationsW Dols, M Verho, B Rangoonwala, et al.Pageof 3